Society guideline links: Blood glucose monitoring

Introduction — This topic includes links to society and government-sponsored guidelines from selected countries and regions around the world. We will update these links periodically; newer versions of some guidelines may be available on each society's website. Some societies may require users to log in to access their guidelines.

The recommendations in the following guidelines may vary from those that appear in UpToDate topic reviews. Readers who are looking for UpToDate topic reviews should use the UpToDate search box to find the relevant content.

Links to related guidelines are provided separately. (See "Society guideline links: Diabetes mellitus in adults" and "Society guideline links: Diabetes mellitus in children" and "Society guideline links: Diabetes mellitus in pregnancy".)

International

●Consensus recommendations for the use of automated insulin delivery technologies in clinical practice (2023)

●Endocrine Society (ES): Clinical practice guideline for the management of hyperglycemia in hospitalized adult patients in non-critical care settings (2022)

●ES: Clinical practice guideline for the management of individuals with diabetes at high risk for hypoglycemia (2022)

●International Society for Pediatric and Adolescent Diabetes (ISPAD): Clinical practice consensus guidelines (2022)

•Diabetes technologies – Glucose monitoring

•Glycemic targets and glucose monitoring for children, adolescents, and young adults with diabetes

●European Association for the Study of Diabetes (EASD) and ISPAD: Position statement on glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes (2020)

●International consensus on use of continuous glucose monitoring (2017)

●International HbA1C Consensus Committee: Consensus statement on the worldwide standardization of the hemoglobin A1C measurement (2010)

Canada

●Choosing Wisely Canada: Don't advise non-insulin requiring diabetics to routinely self-monitor blood sugars between office visits (updated 2022)

●Diabetes Canada (DC): Clinical practice guidelines – Blood glucose monitoring in adults and children with diabetes, update (2021)

•DC: Clinical practice guidelines – Monitoring glycemic control (2018)

●Choosing Wisely Canada: Don't recommend routine or multiple daily self-glucose monitoring in adults with stable type 2 diabetes on agents that do not cause hypoglycemia (updated 2020)

United States

●American Diabetes Association (ADA): Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus (2023)

●ADA: Standards of medical care in diabetes (2023)

•Glycemic targets

●European Association for the Study of Diabetes (EASD) and ADA: Consensus report on automated insulin delivery – Benefits, challenges, and recommendations (2023)

●American Association of Clinical Endocrinology (AACE): Clinical practice guideline – The use of advanced technology in the management of persons with diabetes mellitus (2021)

●EASD and ADA: Consensus report on diabetes digital app technology – Benefits, challenges, and recommendations (2020)

Europe

●European Association for the Study of Diabetes (EASD) and American Diabetes Association (ADA): Consensus report on automated insulin delivery – Benefits, challenges, and recommendations (2023)

●EASD and ADA: Consensus report on diabetes digital app technology – Benefits, challenges, and recommendations (2020)

●EASD and International Society for Pediatric and Adolescent Diabetes (ISPAD): Position statement on glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes (2020)

United Kingdom

●National Institute for Health and Care Excellence (NICE): Guideline on diabetes (type 1 and type 2) in children and young people – Diagnosis and management (2015, updated 2023)

●NICE: Quality standard on type 1 diabetes in adults (2023)

●NICE: Quality standard on type 2 diabetes in adults (2023)

●NICE: Guideline on type 1 diabetes in adults – Diagnosis and management (2015, updated 2022)

●NICE: Guideline on type 2 diabetes in adults – Management (2015, updated 2022)

●Scottish Intercollegiate Guidelines Network (SIGN): Pharmacological management of glycaemic control in people with type 2 diabetes – A national clinical guideline (2017)

●NICE: Diagnostics guidance on integrated sensor-augmented pump therapy systems for managing blood glucose levels in type 1 diabetes (the MiniMed Paradigm Veo system and the Vibe and G4 PLATINUM CGM system) (2016)

India

●Expert consensus recommendations on time in range for monitoring glucose levels in people with diabetes – An Indian perspective (2023)

●Indian Council of Medical Research (ICMR): Guidelines for management of type 1 diabetes (2022)

●ICMR: Guidelines for management of type 2 diabetes (2018)

●Consensus guidelines for glycemic monitoring in type 1/type 2 & GDM (2014)

Australia–New Zealand

●Australian Pediatric Society (APS): Position statement – Guidelines for the use of continuous glucose monitoring (CGM) in Australian schools (updated 2021)

●Choosing Wisely Australia: Don't restrict the ability of people with diabetes to self-manage blood glucose monitoring unless there is a clinical indication to do so (reviewed 2016)

●Choosing Wisely Australia: Avoid multiple daily glucose self-monitoring in adults with stable type 2 diabetes on agents that do not cause hypoglycaemia (reviewed 2015)

Japan

●[In English] Japanese Diabetes Society (JDS): Clinical practice guideline for diabetes 2019 (published 2020)

●[In Japanese] JDS: Diabetes clinical practice guidelines (2019)